These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remission. Papamichael K; Vande Casteele N; Gils A; Tops S; Hauenstein S; Singh S; Princen F; Van Assche G; Rutgeerts P; Vermeire S; Ferrante M Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1103-10. PubMed ID: 25478919 [TBL] [Abstract][Full Text] [Related]
14. Quality of life and colorectal function in Crohn's disease patients that underwent ileocecal resection during childhood. Diederen K; de Ridder L; van Rheenen P; Wolters VM; Mearin ML; de Meij TG; van Wering H; Oomen MW; de Jong JR; Sloots CE; Benninga MA; Kindermann A Eur J Pediatr; 2019 Sep; 178(9):1413-1421. PubMed ID: 31327075 [TBL] [Abstract][Full Text] [Related]
16. Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial). Eshuis EJ; Bemelman WA; van Bodegraven AA; Sprangers MA; Bossuyt PM; van Milligen de Wit AW; Crolla RM; Cahen DL; Oostenbrug LE; Sosef MN; Voorburg AM; Davids PH; van der Woude CJ; Lange J; Mallant RC; Boom MJ; Lieverse RJ; van der Zaag ES; Houben MH; Vecht J; Pierik RE; van Ditzhuijsen TJ; Prins HA; Marsman WA; Stockmann HB; Brink MA; Consten EC; van der Werf SD; Marinelli AW; Jansen JM; Gerhards MF; Bolwerk CJ; Stassen LP; Spanier BW; Bilgen EJ; van Berkel AM; Cense HA; van Heukelem HA; van de Laar A; Slot WB; Eijsbouts QA; van Ooteghem NA; van Wagensveld B; van den Brande JM; van Geloven AA; Bruin KF; Maring JK; Oldenburg B; van Hillegersberg R; de Jong DJ; Bleichrodt R; van der Peet DL; Dekkers PE; Goei TH; Stokkers PC BMC Surg; 2008 Aug; 8():15. PubMed ID: 18721465 [TBL] [Abstract][Full Text] [Related]
17. Postoperative infliximab is not associated with an increase in adverse events in Crohn's disease. Regueiro M; El-Hachem S; Kip KE; Schraut W; Baidoo L; Watson A; Swoger J; Schwartz M; Barrie A; Pesci M; Binion D Dig Dis Sci; 2011 Dec; 56(12):3610-5. PubMed ID: 21681507 [TBL] [Abstract][Full Text] [Related]
18. Indications, Postoperative Management, and Long-term Prognosis of Crohn's Disease After Ileocecal Resection: A Multicenter Study Comparing the East and West. Arkenbosch JHC; Mak JWY; Ho JCL; Beelen EMJ; Erler NS; Hoentjen F; Bodelier AGL; Dijkstra G; Romberg-Camps M; de Boer NKH; Stassen LPS; van der Meulen AE; West R; van Ruler O; van der Woude CJ; Ng SC; de Vries AC Inflamm Bowel Dis; 2022 Jun; 28(Suppl 2):S16-S24. PubMed ID: 34969091 [TBL] [Abstract][Full Text] [Related]
19. Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection. Axelrad JE; Li T; Bachour SP; Nakamura TI; Shah R; Sachs MC; Chang S; Hudesman DP; Holubar SD; Lightner AL; Barnes EL; Cohen BL; Rieder F; Esen E; Remzi F; Regueiro M; Click B Inflamm Bowel Dis; 2023 Jun; 29(6):888-897. PubMed ID: 35905032 [TBL] [Abstract][Full Text] [Related]
20. Surgical treatment of Crohn's disease: indications, results and predictive factors of recurrence and morbidity. Hefaiedh R; Sabbeh M; Miloudi N; Ennaifer R; Romdhane H; Belhadj N; Gharbi L; Khalfallah T Tunis Med; 2015 Jun; 93(6):356-60. PubMed ID: 26644097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]